Stay updated with breaking news from Project Confirm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On April 5, 2023, the U.S. Food and Drug Administration ("FDA") announced its decision to withdraw the approval of Makena® hydroxyprogesterone caproate injection ("Makena"...
U.S. Food and Drug Administration FDA announced decision to withdraw approval of Makena® hydroxyprogesterone caproate injection, drug approved in 2011 to reduce risk of preterm birth in certain pregnant women.
On April 5, 2023, the U.S. Food and Drug Administration (“FDA”) announced its decision to withdraw the approval of Makena® hydroxyprogesterone caproate injection (“Makena”) – a drug...
On April 6, 2023, AbbVie announced that it was voluntarily withdrawing ibrutinib, which was granted accelerated approval for two indications: mantle...
On April 6, 2023, AbbVie announced that it was voluntarily withdrawing ibrutinib, which was granted accelerated approval for two indications: mantle...